< Terug naar vorige pagina

Publicatie

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML : the HOVON-SAKK-132 trial

Tijdschriftbijdrage - Tijdschriftartikel

Tijdschrift: BLOOD ADVANCES

ISSN: 2473-9537

Issue: 4

Volume: 5

Pagina's: 1110 - 1121

Jaar van publicatie:2021

WoS Id: 000621798300016
DOI: https://doi.org/10.1182/bloodadvances.2020003855
Handle: http://hdl.handle.net/1854/LU-8710990

Toegankelijkheid:Open

Zie ook: Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial
Zie ook: Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML